Clinical Trial Update: Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating long-term oral esomeprazole to prevent peptic ulcer rebleeding in high-risk patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Hemorrhage

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: Hsiu-Chi Cheng | Conditions: Peptic Ulcer Hemorrhage | Phase 4 | Status: COMPLETED